vs
Side-by-side financial comparison of AIFU Inc. (AIFU) and Prelude Therapeutics Inc (PRLD). Click either name above to swap in a different company.
AIFU Inc. is the larger business by last-quarter revenue ($12.0M vs $6.5M, roughly 1.8× Prelude Therapeutics Inc). AIFU Inc. runs the higher net margin — 25.3% vs -303.5%, a 328.8% gap on every dollar of revenue.
AIFU vs PRLD — Head-to-Head
Income Statement — Q3 FY2023 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $12.0M | $6.5M |
| Net Profit | $3.0M | $-19.7M |
| Gross Margin | — | — |
| Operating Margin | 5.2% | -314.1% |
| Net Margin | 25.3% | -303.5% |
| Revenue YoY | — | 116.7% |
| Net Profit YoY | — | 38.9% |
| EPS (diluted) | — | $-0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $6.5M | ||
| Q3 24 | — | $3.0M | ||
| Q3 23 | $12.0M | — | ||
| Q2 23 | $21.6M | — | ||
| Q1 23 | $16.6M | — | ||
| Q3 22 | $12.1M | — | ||
| Q2 22 | $14.5M | — | ||
| Q1 22 | $14.9M | — |
| Q3 25 | — | $-19.7M | ||
| Q3 24 | — | $-32.3M | ||
| Q3 23 | $3.0M | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q3 22 | $644.0K | — | ||
| Q2 22 | $591.3K | — | ||
| Q1 22 | $-907.5K | — |
| Q3 25 | — | -314.1% | ||
| Q3 24 | — | -1145.9% | ||
| Q3 23 | 5.2% | — | ||
| Q2 23 | 7.6% | — | ||
| Q1 23 | 7.3% | — | ||
| Q3 22 | 5.1% | — | ||
| Q2 22 | 4.4% | — | ||
| Q1 22 | 3.0% | — |
| Q3 25 | — | -303.5% | ||
| Q3 24 | — | -1075.7% | ||
| Q3 23 | 25.3% | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q3 22 | 5.3% | — | ||
| Q2 22 | 4.1% | — | ||
| Q1 22 | -6.1% | — |
| Q3 25 | — | $-0.26 | ||
| Q3 24 | — | $-0.43 | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q2 22 | — | — | ||
| Q1 22 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $28.3M | $55.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $40.5M | $58.5M |
| Total Assets | $75.8M | $94.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $55.0M | ||
| Q3 24 | — | $153.6M | ||
| Q3 23 | $28.3M | — | ||
| Q2 23 | $30.7M | — | ||
| Q1 23 | $25.5M | — | ||
| Q3 22 | $17.8M | — | ||
| Q2 22 | $22.5M | — | ||
| Q1 22 | $27.9M | — |
| Q3 25 | — | $58.5M | ||
| Q3 24 | — | $156.4M | ||
| Q3 23 | $40.5M | — | ||
| Q2 23 | $37.5M | — | ||
| Q1 23 | $38.1M | — | ||
| Q3 22 | $30.3M | — | ||
| Q2 22 | $31.3M | — | ||
| Q1 22 | $38.0M | — |
| Q3 25 | — | $94.8M | ||
| Q3 24 | — | $197.2M | ||
| Q3 23 | $75.8M | — | ||
| Q2 23 | $79.1M | — | ||
| Q1 23 | $78.4M | — | ||
| Q3 22 | $55.4M | — | ||
| Q2 22 | $57.9M | — | ||
| Q1 22 | $67.2M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $242.5K | $-19.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | 0.08× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $-19.1M | ||
| Q3 24 | — | $-27.3M | ||
| Q3 23 | $242.5K | — | ||
| Q2 23 | $997.1K | — | ||
| Q1 23 | $-376.5K | — | ||
| Q3 22 | $383.8K | — | ||
| Q2 22 | $1.0M | — | ||
| Q1 22 | $-1.9M | — |
| Q3 25 | — | — | ||
| Q3 24 | — | $-27.4M | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q2 22 | — | — | ||
| Q1 22 | — | — |
| Q3 25 | — | — | ||
| Q3 24 | — | -912.0% | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q2 22 | — | — | ||
| Q1 22 | — | — |
| Q3 25 | — | 0.0% | ||
| Q3 24 | — | 2.1% | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q3 22 | — | — | ||
| Q2 22 | — | — | ||
| Q1 22 | — | — |
| Q3 25 | — | — | ||
| Q3 24 | — | — | ||
| Q3 23 | 0.08× | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — | ||
| Q3 22 | 0.60× | — | ||
| Q2 22 | 1.75× | — | ||
| Q1 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AIFU
| Other | $6.5M | 54% |
| Non-life insurance business | $5.5M | 46% |
PRLD
Segment breakdown not available.
